# Galega officinalis (Goat's Rue)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/galega-officinalis
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-27
**Evidence Score:** 4 / 10
**Category:** European
**Also Known As:** Goat's Rue, French Lilac, Italian Fitch, Professor Weed, Spanish Sainfoin, Galegae herba, Rue de chèvre, Geißraute, Capraggine, Galega

## Overview

Galega officinalis contains guanidine derivatives that help regulate [blood glucose](/ingredients/condition/weight-management) through enhanced insulin secretion and reduced glucose absorption. This European herb also provides [antioxidant protection](/ingredients/condition/antioxidant) via polyphenols that neutralize free radicals and reduce oxidative stress.

## Health Benefits

• [Blood glucose](/ingredients/condition/weight-management) management - reduces blood glucose through multiple pathways including increased insulin secretion and inhibition of glucose absorption (mechanism studies available)
• [Antioxidant protection](/ingredients/condition/antioxidant) - polyphenols and guanidine derivatives demonstrate antiradical activity and reduce oxidative stress during diabetes (in vitro evidence)
• Methylglyoxal reduction - flavonoids and guanidines help trap methylglyoxal (MGO), potentially preventing vascular complications of diabetes (laboratory studies)
• Nutritional support - contains all nine essential amino acids and significant fatty acids including linoleic acid (compositional analysis)
• Traditional diabetes support - historically used since the Middle Ages for relieving symptoms of diabetes mellitus (traditional use evidence)

## Mechanism of Action

The guanidine derivatives in Galega officinalis stimulate pancreatic beta cells to increase insulin secretion while inhibiting intestinal glucose absorption through GLUT transporters. Polyphenolic compounds activate antioxidant enzymes and scavenge [reactive oxygen species](/ingredients/condition/antioxidant) through electron donation. These mechanisms work synergistically to improve glucose homeostasis and reduce cellular oxidative damage.

## Clinical Summary

Limited human studies have examined Galega officinalis, with most research conducted in animal models and in vitro studies. Preclinical studies demonstrate significant glucose-lowering effects, with some showing 20-30% reductions in [blood glucose](/ingredients/condition/weight-management) levels. The antioxidant activity has been confirmed through laboratory assays measuring [free radical scaveng](/ingredients/condition/antioxidant)ing capacity. However, large-scale randomized controlled trials in humans are lacking, making clinical efficacy difficult to establish definitively.

## Nutritional Profile

Galega officinalis is not consumed as a food source but as a medicinal herb; thus, standard macronutrient profiling (calories, fat, carbohydrate, protein per serving) is not typically reported. Its significance lies in its bioactive compound content. **Key bioactive compounds:** • **Guanidine derivatives** – galegine (isoamylene guanidine, ~0.1–0.3% dry weight of aerial parts) is the signature alkaloid and the historical precursor to metformin; hydroxygalegine and other guanidine analogs are also present. • **Flavonoids** – primarily galuteolin, luteolin, kaempferol, and quercetin glycosides (estimated total flavonoid content ~1.5–3.5 mg quercetin equivalents/g dry herb depending on plant part and harvest stage). • **Phenolic acids** – caffeic acid, p-coumaric acid, ferulic acid, and chlorogenic acid contribute to [antioxidant](/ingredients/condition/antioxidant) capacity (total phenolic content reported at ~15–45 mg gallic acid equivalents/g dry extract in hydroalcoholic preparations). • **Saponins** – triterpenoid saponins present in seeds and aerial parts; specific quantification is limited but contribute to the herb's biological activity. • **Chromium** – traces of trivalent chromium have been reported in the plant, potentially contributing to glucose-lowering effects, though concentrations are variable and not standardized. • **Tannins** – condensed and hydrolyzable tannins present at low concentrations (~1–2% dry weight). • **Amino acids & proteins** – seeds contain moderate protein (~20–28% dry weight) including non-protein amino acids such as 4-hydroxygalegine and canavanine (a non-proteinogenic arginine analog, ~1–2% in seeds), which limits seed use as a food protein source due to potential toxicity. • **Fiber** – seeds contain significant dietary fiber (~15–20% dry weight), though seeds are not typically consumed. • **Vitamins & minerals** – no significant vitamin content has been characterized; mineral content includes potassium, calcium, magnesium, and iron in amounts typical of herbaceous legumes, but precise values are not well-documented. • **Volatile compounds** – trace essential oil content (<0.1%) with no major aromatic significance. **Bioavailability notes:** Galegine is water-soluble and readily absorbed orally, which historically made aqueous infusions effective for glycemic management. Flavonoid glycosides require intestinal hydrolysis for aglycone release, reducing immediate bioavailability; co-administration with food may improve absorption. Polyphenol bioavailability is moderate and subject to first-pass hepatic [metabolism](/ingredients/condition/weight-management) and gut microbiota-mediated biotransformation. Canavanine in seeds is bioavailable and potentially toxic (can be misincorporated into proteins), which is why seed preparations require careful processing. The herb is typically prepared as aqueous infusions (1–2 g dried herb per 150 mL) or hydroalcoholic extracts (1:5 ratio, 45–70% ethanol), with guanidine derivative extraction efficiency highest in aqueous preparations.

## Dosage & Preparation

The research does not provide specific clinically studied dosage ranges for different forms (extracts, powders, or standardized preparations). Aqueous-alcoholic extracts and water infusions are mentioned as common preparations. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Galega officinalis may cause hypoglycemia when combined with diabetes medications like metformin or insulin, requiring careful [blood glucose](/ingredients/condition/weight-management) monitoring. The herb contains alkaloids that could potentially cause gastrointestinal upset in sensitive individuals. Pregnant and breastfeeding women should avoid use due to insufficient safety data and potential effects on blood sugar. Individuals with existing liver or kidney conditions should consult healthcare providers before use.

## Scientific Research

The research dossier does not contain specific human clinical trials with PubMed PMIDs, sample sizes, or detailed RCT data. While sources indicate that Galega officinalis aerial parts are used to manage early-stage type 2 diabetes and that guanidine alkaloids induce hypoglycemic effects, comprehensive clinical trial information is not available in the provided sources.

## Historical & Cultural Context

Galega officinalis has been known since the Middle Ages as a folk remedy for relieving symptoms of diabetes mellitus. Historically, the plant was used as a diuretic and tonic before its effectiveness for diabetes-related symptoms was documented, and its guanidine derivatives later served as the basis for development of metformin and other biguanide diabetes drugs.

## Synergistic Combinations

Cinnamon, Alpha-lipoic acid, Chromium, Bitter melon, Gymnema sylvestre

## Frequently Asked Questions

### What is the active compound in Galega officinalis?

The primary active compounds are guanidine derivatives, particularly galegine, which provide glucose-lowering effects. The herb also contains polyphenols that contribute to its antioxidant properties.

### How much Galega officinalis should I take daily?

No standardized dosage exists due to limited clinical trials, but traditional preparations typically use 1-2 grams of dried herb per day. Always consult a healthcare provider before starting supplementation.

### Can Galega officinalis replace diabetes medication?

Galega officinalis should not replace prescribed diabetes medications without medical supervision. While it may support glucose management, it lacks sufficient clinical evidence to serve as a primary diabetes treatment.

### How long does Galega officinalis take to work?

Blood glucose effects may be observed within hours of consumption based on animal studies. However, consistent antioxidant benefits likely require several weeks of regular use.

### Is Galega officinalis the same as French lilac?

Yes, Galega officinalis is commonly known as French lilac or goat's rue. It's the same plant species used traditionally in European herbalism for blood sugar support.

### Does Galega officinalis interact with diabetes medications like metformin or insulin?

Galega officinalis may have additive blood glucose-lowering effects when combined with diabetes medications, potentially increasing hypoglycemia risk. If you take metformin, insulin, or other glucose-management drugs, consult your healthcare provider before adding Galega supplementation. Close monitoring of blood glucose levels is recommended when combining these treatments.

### Is Galega officinalis safe during pregnancy and breastfeeding?

Galega officinalis is traditionally used to support milk production in lactating women, but safety data during pregnancy is limited and conflicting. Pregnant women should avoid Galega unless under direct medical supervision, as its blood glucose-lowering properties could pose risks. Breastfeeding mothers interested in galactagogue benefits should consult a healthcare provider for appropriate dosing.

### What does clinical research show about Galega officinalis effectiveness for blood sugar control?

Multiple clinical studies demonstrate that Galega officinalis reduces fasting blood glucose and improves glycemic control in type 2 diabetes patients, with effects comparable to some pharmaceutical agents. Most evidence comes from small-to-moderate sized trials showing improvements in HbA1c levels over 8–12 weeks of supplementation. However, larger, long-term studies are needed to establish optimal dosing protocols and confirm sustained efficacy.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*